CN100496498C - 含有依那普利或贝那普利和索他洛尔的药物组合物 - Google Patents
含有依那普利或贝那普利和索他洛尔的药物组合物 Download PDFInfo
- Publication number
- CN100496498C CN100496498C CNB2005100816701A CN200510081670A CN100496498C CN 100496498 C CN100496498 C CN 100496498C CN B2005100816701 A CNB2005100816701 A CN B2005100816701A CN 200510081670 A CN200510081670 A CN 200510081670A CN 100496498 C CN100496498 C CN 100496498C
- Authority
- CN
- China
- Prior art keywords
- sotalol
- enalapril
- benazepril
- pharmaceutical composition
- hypertension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100816701A CN100496498C (zh) | 2005-07-06 | 2005-07-06 | 含有依那普利或贝那普利和索他洛尔的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100816701A CN100496498C (zh) | 2005-07-06 | 2005-07-06 | 含有依那普利或贝那普利和索他洛尔的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1891222A CN1891222A (zh) | 2007-01-10 |
CN100496498C true CN100496498C (zh) | 2009-06-10 |
Family
ID=37596582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100816701A Active CN100496498C (zh) | 2005-07-06 | 2005-07-06 | 含有依那普利或贝那普利和索他洛尔的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100496498C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104524543A (zh) * | 2014-12-28 | 2015-04-22 | 白玲强 | 一种含依那普利的抗高血压药物组合物及用途 |
-
2005
- 2005-07-06 CN CNB2005100816701A patent/CN100496498C/zh active Active
Non-Patent Citations (4)
Title |
---|
索托洛尔治疗心律失常疗效观察. 刘志华等.临床心血管病杂志,第15卷第5期. 1999 |
索托洛尔治疗心律失常疗效观察. 刘志华等.临床心血管病杂志,第15卷第5期. 1999 * |
高血压的药物治疗. 王丽娟等.实用乡村医生杂志,第7卷第1期. 0200 |
高血压的药物治疗. 王丽娟等.实用乡村医生杂志,第7卷第1期. 0200 * |
Also Published As
Publication number | Publication date |
---|---|
CN1891222A (zh) | 2007-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101528203B (zh) | 用于基于择时治疗理论治疗心血管疾病的联合制剂 | |
EP2830618B1 (en) | Pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or its salt | |
JP5295123B2 (ja) | 新規医薬組成物 | |
CN104107176A (zh) | 治疗高血压和糖尿病肾病的二苯基磺酰胺内皮素和血管紧张素ii受体激动剂的口服制剂 | |
CN102292085A (zh) | 包含氨氯地平和氯沙坦的固体药物组合物及其制备方法 | |
CN100551442C (zh) | 含有钙通道阻滞剂和b族维生素的药物组合物及其用途 | |
CN103006649B (zh) | 一种复方制剂缬沙坦氨氯地平片(ⅰ)及其制备方法 | |
CN102085201A (zh) | 阿替洛尔和氨氯地平的双层片剂 | |
TW201014850A (en) | Solid pharmaceutical composition | |
CN104650091A (zh) | 替格瑞洛的微粉化及其晶型,以及制备方法和药物应用 | |
CN101890165A (zh) | 降压组合物及用途 | |
CN101249083A (zh) | 一种含有氨氯地平和美托洛尔的复方缓释制剂及制备方法 | |
CN101152155A (zh) | 盐酸伊伐布雷定固体药物组合物及其制备方法 | |
CN100496498C (zh) | 含有依那普利或贝那普利和索他洛尔的药物组合物 | |
CN102247366B (zh) | 包括依那普利和非洛地平的药物组合物缓释制剂 | |
CN103249415B (zh) | 包含盐酸乐卡地平和缬沙坦的复合制剂及其制备方法 | |
CN102274223B (zh) | 含替米沙坦和氨氯地平的复方制剂 | |
CN114224859B (zh) | 一种复方降压药物组合物及其制备方法 | |
CN102836161A (zh) | 一种以奥美沙坦酯与苯磺酸氨氯地平及氢氯噻嗪混合组成的药物的复方制剂 | |
CN103860511B (zh) | 一种含有厄贝沙坦和苯磺酸氨氯地平的药用组合物及其制备方法 | |
CN102294032A (zh) | 含有以锌盐形式存在的他汀类药物的药用组合物 | |
CN115124420B (zh) | 大黄酸与苦参碱共晶物水合物及制备方法和其组合物与用途 | |
CN101797250A (zh) | 一种稳定的复方制剂 | |
CN102335178B (zh) | 一种口服固体药用组合物及其制备方法 | |
CN101637609A (zh) | 含氨氯地平、aⅱ受体拮抗剂和他汀类药的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ANHUI BIOLOGICAL MEDICAL INST.; APPLICANT Free format text: FORMER OWNER: ANHUI BIOLOGICAL MEDICAL INST. Effective date: 20080829 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080829 Address after: Box 153, Medical University Of Anhui, Mei mountain road, Shushan District, Anhui, Hefei: 230032 Applicant after: Anhui Biological Medical Institute Co-applicant after: SHENZHEN AUSA PHARMED Co.,Ltd. Address before: Box 153, Medical University Of Anhui, Mei mountain road, Shushan District, Anhui, Hefei: 230032 Applicant before: Anhui Biological Medical Institute |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Medicinal composition containing enalapril or genazepril and sotalol Effective date of registration: 20130523 Granted publication date: 20090610 Pledgee: China Everbright Bank Shenzhen Bagualing branch Pledgor: Anhui Biological Medical Institute|SHENZHEN AUSA PHARMED Co.,Ltd. Registration number: 2013990000307 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20160705 Granted publication date: 20090610 Pledgee: China Everbright Bank, Limited by Share Ltd, Shenzhen, Bagualing branch Pledgor: Anhui Biological Medical Institute|SHENZHEN AUSA PHARMED Co.,Ltd. Registration number: 2013990000307 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20160705 Registration number: 2013990000307 Pledgee after: China Everbright Bank, Limited by Share Ltd, Shenzhen, Bagualing branch Pledgee before: China Everbright Bank Shenzhen Bagualing branch |
|
CP02 | Change in the address of a patent holder |
Address after: 92 mailbox, Medical University Of Anhui, Mei Shan Road, Anhui, Hefei, 230032 Co-patentee after: SHENZHEN AUSA PHARMED Co.,Ltd. Patentee after: Anhui Biological Medical Institute Address before: 153 box 230032, Medical University Of Anhui, Mount Mei Road, Shushan District, Anhui, Hefei Co-patentee before: SHENZHEN AUSA PHARMED Co.,Ltd. Patentee before: Anhui Biological Medical Institute |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230518 Address after: 518057, 1st and 2nd floors of Building 2, Phase III of the Biological Incubator, No. 16, Gaoxin Middle Road, Nanshan District, Shenzhen, Guangdong Province; East side of the first floor and 2nd and 3rd floors of Building 3 Patentee after: SHENZHEN AUSA PHARMACEUTICAL Co.,Ltd. Patentee after: SHENZHEN AUSA PHARMED Co.,Ltd. Patentee after: Anhui Biological Medical Institute Address before: 230032 box 92, Anhui Medical University, Meishan Road, Hefei City, Anhui Province Patentee before: Anhui Biological Medical Institute Patentee before: SHENZHEN AUSA PHARMED Co.,Ltd. |